COVID-2019 Testing and Vaccination Among African American and Latinx Public Housing Residents

• Sponsor: Charles Drew University of Medicine and Science (Other)
• Overall Status: Withdrawn
• CT.gov ID: NCT04542395
• Collaborator: (none)
• Enrollment: 0
• Location: 1
• Arm: 1
• Anticipated Duration (Months): 30
• Patients Per Site Per Month: 0

Study Details

Study Description

Brief Summary

This proposal seeks to enhance acceptability and uptake of COVID-19 testing and vaccination to engage African American and Latinx public housing residents in South Los Angeles. Given the multiple disparities experienced by public housing residents, the investigators will utilize a theoretically-based, multidisciplinary and culturally tailored intervention to reduce barriers and implement innovate strategies to engage this population in the uptake of COVID-19 testing and vaccination.

Condition or Disease	Intervention/Treatment	Phase
Coronavirus	Behavioral: Increasing Willingness and Uptake of COVID-19 Testing and Vaccination	N/A

Detailed Description

Through the engagement and empowerment of 15 trained COVID-19 health ambassadors, the investigators will jointly implement and evaluate a theoretically based and culturally-sensitive socio-behavioral intervention that will: a) reduce mistrust, fatalistic beliefs, and related psychosocial barriers that hinder COVID-19 testing and vaccination; b) increase receptivity and willingness for uptake of COVID-19 testing and vaccination; and c) assess perceived impact of psychosocial and health outcomes related to COVID-19 testing and vaccination for 310 African American and Latinx public housing residents.

Study Design

• Study Type: Interventional
• Actual Enrollment: 0 participants
• Allocation: N/A
• Intervention Model: Single Group Assignment
• Masking: None (Open Label)
• Primary Purpose: Supportive Care
• Official Title: Multilevel Participatory Intervention to Reduce Barriers and Promote Social and Behavioral Facilitators of COVID-19 Testing Among African Americans and Latinx Public Housing Residents
• Anticipated Study Start Date: Jun 1, 2023
• Anticipated Primary Completion Date: Nov 30, 2025
• Anticipated Study Completion Date: Nov 30, 2025

Arms and Interventions

Arm

Intervention/Treatment

Experimental: Increasing Uptake of COVID-19 Testing and Vaccination This is a pre-experimental "one group pretest-posttest" design to improve COVID-19 associated health outcomes and willingness and uptake toward testing and vaccination among 310 Hispanic and African American public housing residents in South Los Angeles. The proposed intervention will employ (1) culturally sensitive, (2) theoretically based intervention that will be jointly delivered by our COVID-19 health ambassadors and our researchers. We will use the Information, Motivation, and Behavioral Skills (IMB) model and the Transtheoretical Model to implement the intervention.

Behavioral: Increasing Willingness and Uptake of COVID-19 Testing and Vaccination; Provide/enhance knowledge, modify attitudes, motivate and provide skills and resources to reduce COVID-19 related risk and challenges and increase willingness and uptake in COVID-19 testing and vaccination.

Outcome Measures

Primary Outcome Measures

1. Prevalence of COVID-19 testing, pneumococcal and influenza vaccinations Using Test History Self-Report [Intervention: 3 months; Follow-up Point: 6 months post-intervention]

   By comparison of pre-, post- intervention, and six-months follow-up data, we anticipate the following compared to baseline: a 30% change in willingness and uptake for testing and vaccination.

2. Percentage of Participants Achieving Decreased Levels of COVID-19 Risk Using the NIH Toolbox Surveys on COVID-19 [Intervention: 3 months; Follow-up Point: 6 months post-intervention]

   By comparison of pre-, post- intervention, and six-months follow-up data, we anticipate the following compared to baseline: a 30% change in perceived COVID-19 risk.

3. Percentage of Participants Achieving Decreased Levels of COVID-19 Mistrust and Barriers Using the NIH Toolbox Surveys on COVID-19 [Intervention: 3 months; Follow-up Point: 6 months post-intervention]

   By comparison of pre-, post- intervention, and six-months follow-up data, we anticipate the following compared to baseline: a 40% change in mistrust and perceived barriers toward COVID-19 testing and vaccination,

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• Identify as Latino/Hispanic or African American/Black

• Reside in one of the six collaborating public housing

• 18 years old and older

• Speak either English or Spanish

Exclusion Criteria:

• Does not self-identify as African American and/or Black

• Under the age of 18

• Unable to speak English or Spanish

• Does not Reside in one of the six collaborating public housing

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Housing Authority of Clty of Los Angeles	Los Angeles	California	United States	90059

Sponsors and Collaborators

• Charles Drew University of Medicine and Science

Investigators

• Principal Investigator: Mohsen Bazargan, PhD, Charles R. Drew University of Medicine & Science

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Charles Drew University of Medicine and Science
• ClinicalTrials.gov Identifier: NCT04542395
• Other Study ID Numbers: COVID19testingvacc
• First Posted: Sep 9, 2020
• Last Update Posted: Aug 19, 2022
• Last Verified: Aug 1, 2022

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Coronavirus Infections

Study Results

No Results Posted as of Aug 19, 2022